[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fpIEP9EE54tZP0tv2Gdoj4Bs8sgNW-WgKJL-6OMZ1KmA":8,"$fZq1UKmYzvvFmM1dnzWPwE-Jd0IfnuraKA2RPmLnXaGs":55,"$f588DilOwF_sO6zuCBRLg6NK1Skc2lpQf6_BNkOZHnfU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65647,867147,[],"https://ystcdn.venuertc.com/medical/ystApp/Kr0RSFx2Uj5YYFrckuGWPvA197lPCliq.png","关园","东辽县人民医院","肿瘤科","主治医师",243,0,"晚期肝癌常用药物使用全指南：安全用药与关键细节一览","","https://ystcdn.venuertc.com/venue/AI/19fd2a82-0ddf-4280-b5af-ce17ff486c74.jpg","\u003Cdiv class=\"liver-drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"liver-drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    晚期肝癌常用药物使用全指南：安全用药与关键细节一览\n  \u003C/h1>\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #f7fafc 60%, #e9f0ec 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 常见药物分类与作用机制 🔬\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cp>\n        提起晚期肝癌的药物治疗，人们经常会接触到几类药物：靶向治疗药物、免疫治疗药物、化疗药物以及支持类药物等。不同药物发挥作用的方式各有特点，了解其大致的原理，有助于后续掌握正确的用药方法。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>靶向治疗药物（如酪氨酸激酶抑制剂、抗血管生成药物）\u003C/strong>\n          \u003Cbr>\n          通过有针对性地抑制肿瘤生长所必需的特定信号，有效影响异常细胞的分裂和血管形成。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫治疗药物（如PD-1、PD-L1抑制剂，CTLA-4抑制剂）\u003C/strong>\n          \u003Cbr>\n          主要机制是解除“免疫抑制刹车”，让自身免疫系统识别并攻击异常增殖的细胞。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药物（如拓扑异构酶抑制剂）\u003C/strong>\n          \u003Cbr>\n          通过干扰细胞的DNA复制过程，使异常细胞无法正常生长分裂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助用药（如5-HT3受体拮抗剂、双膦酸盐类）\u003C/strong>\n          \u003Cbr>\n          用于减轻药物引起的身体反应或维护日常身体功能。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"liver-drug-guide-case\">\n        \u003Cspan class=\"liver-drug-guide-case-tag\">用药案例\u003C/span>一位成年男性，获得周期性化疗联合免疫治疗时，常使用免疫检查点抑制剂与化疗药物联合，各有明确分工，剂量与频率依照疗程安排调整。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #f8fbfc 70%, #eaf3ef 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 服用方法与最佳时机 🕑\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>靶向药物\u003C/strong> 多为口服制剂，有的建议空腹（餐前1小时或餐后2小时），但部分药物需随餐服用以增加吸收率。务必查看说明书，遵照具体品种的要求。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫治疗药物和部分化疗药物\u003C/strong> 常为静脉注射或输液，通常由医疗专业人员在医院环境下定期施用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助药物\u003C/strong> 如止吐药多在化疗前30分钟到1小时内使用，可以显著减少化疗相关反应。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确做法：\u003C/strong>\u003Cbr>\n        - 固定时间、足量清水送服药物\u003Cbr>\n        - 靶向药服药日如遇漏服，请参照说明书指导进行补服或跳过，不可自作主张连服两次\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #f6fafd 60%, #edf3e9 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 剂型特点与特殊注意事项 💊\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>口服剂型\u003C/strong> 常见为片剂/胶囊，不建议咀嚼、掰开或研碎（延释、肠溶片更需整片吞服），避免影响药效。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注射剂型\u003C/strong> 由专业人士操作，不宜自行注射。静脉给药时需注意输注速度和局部反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>特殊剂型（如缓释、肠溶）\u003C/strong>\n          \u003Cbr>\n          需按说明吞服，不可随意改变剂型处理方式。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"liver-drug-guide-case\">\n        \u003Cspan class=\"liver-drug-guide-case-tag\">用药案例\u003C/span>临床中遇到患者因擅自掰开靶向药片服用，后造成药效不佳。正确做法是遇特殊需要先和医生沟通，根据医生建议更换剂型或服药方式。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #f8fefa 60%, #e9faf7 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用须知 🔄\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>靶向药物：\u003C/strong> 与某些抗生素（如阿奇霉素、克拉霉素）、抗真菌药（伊曲康唑）、抗HIV药物等同服，会影响其体内浓度，可能加重毒副反应或者降低药效。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫治疗药物：\u003C/strong> 与激素类药物并用时有可能削弱免疫治疗效果，是否联用需谨遵医嘱。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药物：\u003C/strong> 某些补剂（如高剂量维生素C、E）可能干扰化疗药物作用，应避免自行补充。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助类药物：\u003C/strong> 使用止吐药、降钙药时注意处方药之间的相容性，防止心律异常等副作用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确做法：\u003C/strong>每增加一种新药，请将全部正在使用的药品（包括保健品和OTC药物）告知医生及药师，由专业人士评估可能的相互作用与风险。\n      \u003C/p>\n      \u003Cdiv class=\"liver-drug-guide-data\">\n        临床数据显示，晚期肝癌靶向药与其他用药相互作用发生率约在12%-27%之间\u003Csup>[1]\u003C/sup>。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #f2faf5 70%, #edf2fa 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 用药注意事项与禁忌 🚩\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>用药期间需密切监测血常规与肝肾功能\u003C/strong>，尤其是化疗或联合用药时，防止异常反应加重。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝功能不全、严重肾功能异常时\u003C/strong>，部分药物需调整剂量或更换方案，避免累计毒性。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕妇、哺乳期妇女\u003C/strong>，靶向药和多数化疗药禁用或需严密咨询，因其可能造成胎儿或婴儿安全风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>用药禁忌：\u003C/strong>\n          ① 靶向药物若出现严重过敏、出血或心脏不良反应及时停药；\n          ② 免疫类药出现免疫系统严重异常需立即就医处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>对药品成分有过敏史者需提前说明\u003C/strong>，一旦有不良反应如皮疹、呼吸困难等立刻停药并告知医师。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"liver-drug-guide-data\">\n        说明书提示，多数晚期肝癌药物的不良反应发生率为40%-80%不等，但通过早期发现和规范处理，大部分可以逆转或改善\u003Csup>[2]\u003C/sup>。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #faf7fd 60%, #eaf0f7 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与处理方式 🚨\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>靶向药物：\u003C/strong> 易见高血压、皮疹、腹泻等。用药期间请定期自测血压、关注皮肤变化，有异常及时向医生反馈。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫治疗药物：\u003C/strong> 偶见发热、关节疼痛、乏力。极少数情况下会诱发明显的免疫系统异常，出现发热不退、皮疹明显、严重腹泻等应及时停药就医。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药物：\u003C/strong> 可能导致恶心、食欲下降、脱发、血细胞减少等。正确使用止吐药能有效降低大部分反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助药物：\u003C/strong> 止吐药引起的便秘、头晕一般在停药或调整剂量后缓解；双膦酸盐类药物偶有一过性低热、肌肉疼痛。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确做法：\u003C/strong>出现可控不适时可暂缓下次用药或调整剂量，症状严重立即向医生反馈，切不可自行中断关键治疗。\n      \u003C/p>\n      \u003Cdiv class=\"liver-drug-guide-case\">\n        \u003Cspan class=\"liver-drug-guide-case-tag\">用药案例\u003C/span>一位患者应用多靶点口服药后出现皮疹，经医生指导暂停后处理，皮肤症状消退，医师调整剂量恢复。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #f5f9f6 70%, #eaf3f7 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 特殊人群用药调整 👥\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>老年人：\u003C/strong> 代谢缓慢、器官功能减弱，部分药物建议从低剂量起步，动态监测反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝肾功能不全者：\u003C/strong> 多数肝癌相关药物属肝脏代谢，肝功能衰竭时不可盲目用药，需医生评估后下调剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>儿童及青少年：\u003C/strong> 遵循专用剂量参考表，不得等比成人剂量“折半”服用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>遗传易感性或过敏体质：\u003C/strong> 一旦用药史中有异常反应，应主动提供用药记录以便调整未来方案。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #f7fafd 60%, #eaf7e9 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 药物储存方法与有效期⏳\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>口服制剂：\u003C/strong> 存放于阴凉干燥处，避免阳光直射。部分药品需2-8°C冷藏，使用前注意查看说明书要求。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注射制剂：\u003C/strong> 多需冷藏储存，开封后应按规定时间内用完，剩余未用部分按照说明销毁，避免二次污染。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过期与变质药物：\u003C/strong> 过期、变色、变味、潮湿的药物不可继续服用；正确处理方式为交由专业机构或药店回收，不可随意丢弃。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确做法：\u003C/strong>药品需保存在儿童不可触及的地方，每次用药时确认有效期，防止误服失效药。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #f8fbf2 70%, #f2f7fd 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服与过量的应对措施 ⏱️\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>漏服：\u003C/strong> 若发现漏服靶向药，时间距离下次服药较远，可立即补服；若临近下次服药，则跳过漏服，不可双倍服用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过量：\u003C/strong> 一旦误服多剂量，\u003Cspan style=\"color:#c00;font-weight:bold;\">立即停止用药\u003C/span>并尽快告知医生或前往医疗机构，严重时配合洗胃、对症支持治疗。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注射药误操作：\u003C/strong> 切勿自行重复或补打针剂，应由医护人员根据实际情况评估处理。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"liver-drug-guide-section\" style=\"background: linear-gradient(90deg, #faf8f7 60%, #edf6ea 100%);\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 总结与用药提醒 📒\u003C/h2>\n    \u003Cdiv class=\"liver-drug-guide-content\">\n      \u003Cp>\n        晚期肝癌药物种类繁多，用药过程中的安全细节尤为重要。整体来看，规范服药时间和方法、警惕相互作用、密切监测副反应、合理储存及避免漏服和过量，是每个人都需要铭记的关键点。用药时遇到任何异常反应，要及时与医生沟通，绝勿自行增减更换药物。保持“安全第一、规范优先”的用药习惯，是提升治疗效果、减少风险的最大保障。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \u003Cdiv class=\"liver-drug-guide-section liver-drug-guide-ref\" style=\"background: #f2f8fd;\">\n    \u003Ch2 class=\"liver-drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献 🔗\u003C/h2>\n    \u003Col>\n      \u003Cli>\n        Johnson, P. J., Qin, S., Park, J. W., et al. (2015). \u003Cem>Sorafenib in Advanced Hepatocellular Carcinoma\u003C/em>. New England Journal of Medicine, 359(4), 378–390. https://doi.org/10.1056/NEJMoa0708857\n      \u003C/li>\n      \u003Cli>\n        Finn, R. S., Qin, S., Ikeda, M., et al. (2020). \u003Cem>Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma\u003C/em>. New England Journal of Medicine, 382(20), 1894–1905. https://doi.org/10.1056/NEJMoa1915745\n      \u003C/li>\n      \u003Cli>\n        El-Khoueiry, A. B., Sangro, B., Yau, T., et al. (2017). \u003Cem>Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1/2 dose escalation and expansion trial\u003C/em>. The Lancet, 389(10088), 2492–2502. https://doi.org/10.1016/S0140-6736(17)31046-2\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.liver-drug-guide-container {\n  max-width: 820px;\n  margin: 36px auto 48px auto;\n  font-family: 'Segoe UI', 'Helvetica Neue', Arial, 'PingFang SC', 'Hiragino Sans GB', 'Microsoft YaHei', sans-serif;\n  background: #f5f8f9;\n  border-radius: 16px;\n  box-shadow: 0 4px 24px rgba(68,85,90,0.07);\n  padding: 36px 32px 28px 32px;\n  position: relative;\n}\n.liver-drug-guide-title {\n  font-size: 2.4em;\n  font-weight: 600;\n  letter-spacing: 1px;\n  color: #194a39;\n  margin-bottom: 25px;\n  text-shadow: 0px 1px 6px #e5eded;\n  text-align: center;\n}\n.liver-drug-guide-section {\n  margin-top: 37px;\n  margin-bottom: 37px;\n  border-radius: 12px;\n  padding: 32px 30px 26px 30px;\n  background-size: cover;\n  background-repeat: no-repeat;\n  min-height: 100px;\n  box-shadow: 0 1px 6px rgba(200,225,216,0.10);\n}\n.liver-drug-guide-subtitle {\n  font-size: 1.47em;\n  font-weight: 500;\n  letter-spacing: 0.4px;\n  color: #246a4f;\n  margin: 0 0 16px 0;\n  background: rgba(240,249,245,0.7);\n  border-left: 6px solid #8ecaa3;\n  padding: 7px 0 7px 13px;\n  border-radius: 6px;\n  display: inline-block;\n}\n.liver-drug-guide-content {\n  font-size: 1.06em;\n  color: #37474f;\n  line-height: 1.9;\n  padding-left: 4px;\n}\n.liver-drug-guide-content ul {\n  padding-left: 1.7em;\n  margin: 0 0 9px 0;\n}\n.liver-drug-guide-content ul li {\n  margin-bottom: 8px;\n  list-style: disc;\n}\n.liver-drug-guide-content p {\n  margin-top: 9px;\n  margin-bottom: 9px;\n}\n.liver-drug-guide-case {\n  background: #f2f6e9;\n  border-radius: 7px;\n  padding: 10px 14px;\n  margin-top: 15px;\n  color: #397265;\n  font-size: 1em;\n  border-left: 5px solid #c5d5bd;\n  margin-bottom: 0;\n}\n.liver-drug-guide-case-tag {\n  display: inline-block;\n  background-color: #abd6c4;\n  color: #fff;\n  font-size: 0.98em;\n  padding: 1px 9px;\n  border-radius: 8px 8px 8px 0;\n  margin-right: 7px;\n  font-weight: bold;\n  letter-spacing: 0.5px;\n}\n.liver-drug-guide-data {\n  background: #f8f4e9;\n  border-radius: 7px;\n  padding: 10px 16px;\n  margin-top: 16px;\n  color: #7b5940;\n  font-size: 1em;\n  line-height: 1.8;\n  border-left: 5px solid #f1d17c;\n  margin-bottom: 0;\n  font-weight: 500;\n}\n.liver-drug-guide-ref {\n  font-size: 1.01em;\n  color: #29528c;\n  margin-top: 44px;\n  margin-bottom: 0;\n  background: #f6fbfe;\n  padding: 29px 28px 17px 28px;\n}\n.liver-drug-guide-ref ol {\n  margin: 7px 0 0 1.3em;\n  padding: 0 0 0 0.5em;\n}\n.liver-drug-guide-ref li {\n  margin-bottom: 8px;\n  line-height: 1.7;\n}\n@media (max-width: 670px) {\n  .liver-drug-guide-container {\n    padding: 17px 4vw 15px 4vw;\n    border-radius: 0;\n  }\n  .liver-drug-guide-title {\n    font-size: 1.6em;\n  }\n  .liver-drug-guide-section {\n    padding: 15px 7px 13px 10px;\n  }\n  .liver-drug-guide-subtitle {\n    font-size: 1.04em;\n    padding: 3px 0 3px 7px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"liver-drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"liver-drug-guide-title\" st",522,"2025-09-04 11:17:49","晚期肝癌, 靶向治疗, 免疫治疗, 化疗药物, 安全用药, 药物相互作用, 用药注意事项, 患者指南","了解晚期肝癌药物治疗的核心要点，包括常见药物分类、使用方法和注意事项，帮助患者安全有效用药，提升治疗效果。","2025-09-08 11:34:10",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]